Gsk Plc ADR (GSK)

Jan 14, 2025, 6:13 PM EST - 3 days ago

Hallucinations in AI: How GSK is addressing a critical problem in drug development

Jan 14, 2025, 4:31 PM EST - 3 days ago

Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals

AMZN LLY DXCM JNJ MRNA NVDA TDOC

Jan 14, 2025, 12:56 PM EST - 3 days ago

GSK plc (GSK) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)

Jan 13, 2025, 8:00 PM EST - 4 days ago

Healthcare sector poised for rebound in 2025

JNJ LLY XLV

Jan 13, 2025, 6:10 PM EST - 4 days ago

Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025

ABBV AMGN AZN BNTX FBCG GILD IBB

Jan 13, 2025, 12:39 PM EST - 4 days ago

GSK CEO on acquisition of biotech firm IDRx

Jan 13, 2025, 12:07 PM EST - 4 days ago

Drugmakers rush to sign deals on first day of industry conference

ABBV ITCI JNJ LLY

Jan 13, 2025, 2:10 AM EST - 4 days ago

GSK to buy US biotech firm IDRx for up to $1.15 billion

Jan 13, 2025, 2:05 AM EST - 4 days ago

GSK Enters Agreement to Acquire IDRx, Inc.

Jan 7, 2025, 6:20 PM EST - 10 days ago

GSK and Pfizer's RSV vaccines to carry warnings of neurological disorder risk

PFE

Dec 20, 2024, 2:35 AM EST - 4 weeks ago

GSK's cancer drugs meet progression-free survival goal in late-stage trial

Dec 10, 2024, 7:00 AM EST - 5 weeks ago

Relation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and osteoarthritis

Dec 9, 2024, 1:37 PM EST - 5 weeks ago

GSK's drug combo shown to cut risk of death by 42% in type of blood cancer

Dec 6, 2024, 1:28 PM EST - 6 weeks ago

Final Trades: Oracle, Vertiv Holdings and GSK

ORCL VRT

Dec 5, 2024, 3:40 AM EST - 6 weeks ago

GSK, China's Zhifei Expand Shingles Shot Collaboration

Dec 5, 2024, 2:29 AM EST - 6 weeks ago

GSK expands deal with China's Zhifei to explore RSV vaccine collaboration

Nov 22, 2024, 2:50 AM EST - 2 months ago

GSK's RSV vaccine gets Japan approval for adults aged 50 to 59

Nov 19, 2024, 4:05 AM EST - 2 months ago

GSK share price is imploding: is it safe to buy the dip?

Nov 19, 2024, 2:19 AM EST - 2 months ago

GSK drug meets main goal in late-stage study to treat relentless itch

Nov 15, 2024, 10:03 PM EST - 2 months ago

As Drug Maker Stocks Fall, Pressure Builds On PhRMA To Derail RFK, Jr.

JNJ LLY MRK MRNA PFE

Nov 15, 2024, 11:43 AM EST - 2 months ago

GSK plc (GSK) Guggenheim's Inaugural Healthcare Innovation Conference (Transcript)

Nov 15, 2024, 11:21 AM EST - 2 months ago

European And US Vaccine Stocks Are Under Pressure - Here's WHy

AZN BNTX INO MRK SNY VALN

Nov 15, 2024, 7:21 AM EST - 2 months ago

Pharma shares hit as Trump picks RFK Jr to lead health department

AZN BNTX MRNA PFE

Nov 14, 2024, 4:12 PM EST - 2 months ago

Vaccine maker stocks fall on reports Trump plans to tap RFK Jr. to lead HHS

MRNA NVAX PFE BNTX

Nov 5, 2024, 9:51 AM EST - 2 months ago

Canada approves GSK's RSV vaccine for adults aged 50 to 59

Oct 30, 2024, 1:18 PM EDT - 2 months ago

GSK plc (GSK) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 9:19 AM EDT - 2 months ago

GSK: Earnings Confirm It's On Track To Meet Guidance

Oct 30, 2024, 8:58 AM EDT - 2 months ago

GSK's Q3 Earnings Hit By Lower Than Expected Vaccine Sales, Cautions Lower Revenue For 2024

Oct 30, 2024, 8:40 AM EDT - 2 months ago

GSK Stock Drops as UK Firm Posts Underwhelming Results

Oct 30, 2024, 7:17 AM EDT - 2 months ago

GSK cuts vaccine sales target on reduced demand

Oct 30, 2024, 3:06 AM EDT - 2 months ago

GSK lowers 2024 vaccine sales forecast

Oct 28, 2024, 6:30 PM EDT - 2 months ago

Clover Announces Positive Clinical Data for RSV Vaccine Candidate SCB-1019 Compared Head-to-Head Versus GSK's AREXVY

Oct 26, 2024, 9:30 AM EDT - 2 months ago

GSK Q3 Earnings Preview: Shingrix And Arexvy Make The Stock A 'Strong Buy'

Oct 24, 2024, 7:00 AM EDT - 3 months ago

New Data for AREXVY, GSK's Respiratory Syncytial Virus Vaccine, Show Potential to Help Protect a Broader Group of Adults at Increased Risk for RSV Disease

Oct 15, 2024, 10:20 AM EDT - 3 months ago

GlaxoSmithKline sues Moderna for US patent infringement over COVID vaccines

MRNA

Oct 10, 2024, 11:13 AM EDT - 3 months ago

GSK: The Worst Is Finally Over (Rating Upgrade)

Oct 10, 2024, 7:47 AM EDT - 3 months ago

GSK Shares Climb on $2.2 Billion Zantac Lawsuit Settlement

Oct 10, 2024, 7:15 AM EDT - 3 months ago

GSK Stock Jumps as UK Drug Giant Resolves Most US Zantac Lawsuits

Oct 10, 2024, 7:01 AM EDT - 3 months ago

GSK jumps 6% after $2.2B Zantac settlement: why analysts see more upside

Oct 10, 2024, 4:54 AM EDT - 3 months ago

GSK settles vast majority of Zantac claims for $2.2 billion

Oct 10, 2024, 2:43 AM EDT - 3 months ago

GSK shares seen opening higher after settlement of 80,000 Zantac lawsuits

Oct 9, 2024, 2:43 PM EDT - 3 months ago

GSK strikes $2.2bn deal to resolve legal cases in US over heartburn treatment Zantac

Oct 9, 2024, 2:01 PM EDT - 3 months ago

GSK to Pay Over $2 Billion in Bid to End Most U.S. Zantac Lawsuits

Oct 9, 2024, 1:50 PM EDT - 3 months ago

GlaxoSmithKline Reaches $2.2 Billion Settlement in Zantac Lawsuits

Oct 9, 2024, 1:00 PM EDT - 3 months ago

GSK reaches up to $2.2 billion settlement in Zantac US state court cases

Oct 8, 2024, 11:31 AM EDT - 3 months ago

GSK Reports Sustained Efficacy of RSV Vaccine Amidst Competition from Pfizer and Moderna

Oct 8, 2024, 11:10 AM EDT - 3 months ago

RSV Vaccine Demand Drops Sharply in the US, Impacting GSK's Sales

Oct 8, 2024, 7:00 AM EDT - 3 months ago

GSK Presents Positive Data for AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Indicating Protection Over Three RSV Seasons

Oct 8, 2024, 6:50 AM EDT - 3 months ago

GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up

PFE

Oct 8, 2024, 6:47 AM EDT - 3 months ago

GSK RSV shot 43% effective against severe disease in third year